The BCAN Patient-Centered Clinical Research Award supports investigators launching or expanding careers in patient-centered clinical research focused on bladder cancer or upper tract urothelial carcinoma. Projects should emphasize improving patient experiences, outcomes, and equity in care delivery, addressing topics such as shared decision-making, access to care, survivorship, and quality of life.
Eligibility criteria:
-
Applicants must hold a doctoral degree (MD, DO, PhD, DNP, etc.) and a full-time faculty appointment (assistant professor or higher) at a U.S. or Canadian academic, nonprofit, or governmental institution.
-
Applicants must dedicate at least 30% of full-time effort to research.
-
A primary Co-Investigator with expertise in patient-centered clinical research is required.
-
Applicants must not have received an NIH R01 or equivalent in patient-centered clinical research but may have prior awards in other research areas.
-
Only one proposal per applicant per cycle; no concurrent BCAN awards allowed.
Funding details:
-
Total funding: 250,000 USD over 3 years.
-
Support limited to 20% of PI salary (up to 50,000 USD total).
-
Up to 7% indirect costs allowed.
-
Funds may cover personnel, research supplies, travel, and patient engagement activities.
-
Annual progress reports required; continued funding contingent on satisfactory progress.
-
Award recipients must attend and present at the 2029 BCAN Think Tank Meeting.
Deadline:
-
Application due: December 2, 2025, at 5:00 p.m. Eastern Time.
-
Award decision: March 2026.
-
Earliest grant start date: April 1, 2026.
Where to go for further information:
- Applications must be submitted via ProposalCentral.
- Questions about guidelines or eligibility: Rebecca Johnson ([email protected]) or Anne Collins ([email protected]).